Document:

exv10w13

 

Exhibit 10.13

Tomkins Capital Group Letterhead

October 25, 2006

Mr. Joel A. Balbien

Chief Executive Officer

Kreido Laboratories

1140 Avenida Acaso

Camarillo, CA 93012

Dear Mr. Balbien:

We refer to that certain term sheet dated September 1, 2006 (the “Term Sheet”) between Tompkins
Capital Group (“TCG”) and Kreido Laboratories (“Kreido”) with respect to a reverse triangular
merger and a PPO (as defined therein) and related transactions (“Transactions”). Capitalized terms
not defined in this letter shall have the meanings given to them in the Term Sheet.

TCG and Kreido desire to amend certain provisions of the Term Sheet.

Accordingly, the Term Sheet is hereby amended as follows;

The first and second paragraphs of the Provision entitled “1. Structure” in the Term Sheet are
hereby deleted in their entirety and replaced with the following:

	 	 	 
	1. Structure.

	 	Pubco, a publicly traded company currently listed on the
NASD OTC Bulletin Board and not registered under the
Securities Exchange Act of 1934, as amended, will enter into
a reverse triangular merger with Kreido and a newly formed
acquisition subsidiary of Pubco, which merger shall qualify
as a tax-free reorganization under the Internal Revenue
Code, and pursuant to which Pubco will acquire all the
outstanding shares of Kreido (the “Merger”) in exchange for
shares of Pubco common stock (“Common Stock”) with an
anticipated closing date on or before November 30, 2006 (the
“Closing Date”). Following the Closing Date, Pubco will
change its name to such other alternate name as shall be
determined by Kreido.
	 
	 	 
	 

	 	Upon the Closing Date, and as a precondition for Kreido
participation in the Merger, Pubco shall have closed on
private placement financing of units (“Units”) of Pubco
securities as discussed in Section 4 below, and the Board of
Directors of Pubco shall have adopted, subject to
shareholder approval following the Closing Date, a Three
Million Eight Hundred and Fifty Thousand (3,850,000) Share
Employee Incentive Stock Option Plan (“ESOP”).

 

 

 

The final sentence of the final paragraph of the Provision entitled “2. Merger”
in the Term Sheet is hereby deleted in its entirety and replaced with the
following:

The value of the R&W Shares
issued pursuant to the
adjustment mechanism will be
fixed at the per Unit price
of Units sold in the PPO as
defined below (which price
is currently contemplated to
be $1.35 per Unit).

The Provision entitled “3. Consideration” in the Term Sheet is hereby deleted
in its entirety and replaced with the following:

	 	 	 
	3. Consideration

	 	In consideration for the Merger, the
stockholders of Kreido shall receive Twenty
Seven Million (27,000,000) shares of Common
Stock of Pubco in exchange for all the
shares of common stock of Kreido. The shares
of Common Stock of Pubco received by the
stockholders of Kreido shall represent
approximately fifty five percent (55.0%) of
the shares of Common Stock of Pubco, if the
Minimum PPO, as such term is defined below,
is sold, and approximately fifty one and
nine tenths percent (51.9%) of the shares of
Common Stock of Pubco, if the Maximum PPO,
as such term is defined below, is sold, in
each case on a fully diluted basis after
giving effect to the Merger and the shares
of Common Stock issued in the PPO but not
the shares granted under the ESOP, or the
R&W Shares or the Investor Warrants, as
defined below. For purposes of the Merger,
Kreido’s capitalization table shall be
frozen as of October 31, 2006, and Kreido
shall be authorized to issue (“Bridge
Notes”) to satisfy its working capital needs
pending the closing of the Transactions.
Bridge Notes issued after October 31, 2006
and on or before November 30, 2006 shall,
and Bridge Notes issued after November 30,
2006 at the discretion of the lender may,
convert in their entirety into Units in the
PPO, at a conversion price identical to the
price per Unit in the PPO (which currently
is anticipated to be $1.35 per Unit), upon
the close of the PPO.
	 
	 	 
	 

	 	In consideration for the Merger, the
stockholders of Pubco will retain Eight
Million Seven Hundred and Fifty Thousand
(8,750,000) shares of Common Stock of Pubco
representing approximately seventeen and
eight tenths percent (17.8%) of the shares
of Common Stock of Pubco, if the Minimum PPO
is sold, and approximately sixteen and eight
tenths percent (16.8%) of the shares of
Common Stock of Pubco, if the Maximum PPO is
sold, in each case on a fully diluted basis
after giving effect to the Merger and the
shares of Common Stock issued in the PPO but
not the shares granted under the ESOP, or
the R&W Shares or the Investor Warrants.

 

 

 

	 	 	 
	 

	 	The investors in the PPO will own:

	 	(a)	 	Thirteen Million Three Hundred and
Thirty Three Thousand Three Hundred and
Thirty Four (13,333,334) shares of Common
Stock of Pubco representing approximately
twenty seven and two tenths percent (27.2%)
of the shares of Common Stock of Pubco, if
the Minimum PPO is sold; and

	 
	 	(b)	 	Sixteen Million Two Hundred and Ninety
Six Thousand Two Hundred and Ninety Seven
(16,296,297) shares of Common Stock of
Pubco, representing approximately thirty one
and three tenths percent (31.3%) of the
 shares of Common Stock of Pubco if the
Maximum PPO is sold,

	 	 	 
	 

	 	in each case on a fully diluted basis after
giving effect to the Merger and the shares
of Common Stock issued in the PPO, but not
the shares granted under the ESOP, or the
R&W Shares or the Investor Warrants.
	 
	 	 
	 

	 	Subject to the cancellation of the 2,000,000
R&W Shares held in escrow as provided in the
last paragraph of Section 2 above, the total
shares of Common Stock of Pubco outstanding
after giving effect to the Transactions on a
fully diluted basis will be approximately
59,600,001 shares, if the Minimum PPO is
sold, and approximately 64,044,446 shares,
if the Maximum PPO is sold, in each case
including the shares reserved for issuance
under the ESOP and the shares reserved for
issuance under the Investor Warrants.

The first paragraph of the Provision entitled “4. Private Placement Offering”
in the Term Sheet is hereby deleted in its entirety and replaced with the
following:

	 	 	 
	4. Private Placement Offering

	 	Pubco will conduct a private placement
offering pursuant to Regulation D
of the Securities Act and any and all
applicable state securities laws (the “PPO”)
of a minimum (the “Minimum PPO”) of Thirteen
Million Three Hundred and Thirty Three
Thousand Three Hundred and Thirty Four
(13,333,334) Units of its securities, and a
maximum (the “Maximum PPO”) of Sixteen
Million Two Hundred and Ninety Six Thousand
Two Hundred and Ninety Seven (16,296,297)
Units of its securities, in each case
including any securities issued upon the
conversion of Bridge Notes, at an offering
price of $1.35 per Unit. Each unit shall
consist of one (1) share of Common Stock and
one half of one common stock purchase
warrant (“Investor Warrants”). Each Investor
Warrant will entitle the holder thereof to
purchase one share of Pubco Common Stock, at
an exercise price of $1.85 per share, and
will be exercisable for a period of five (5)
years from the Closing Date.

 

 

 

	 	 	 
	 

	 	Broker-dealers who introduce investors to
the PPO will be paid a commission of seven
percent (7%) of funds raised from such
investors in the PPO.

The following language is added at the end of the Provision entitled “9.
Restriction on Sale” in the Term Sheet:

	 	 	 
	 

	 	At Closing, the principals of Kreido shall
enter into Lock-Up Agreements with Pubco for
a term of 12 months whereby they agree to
certain restrictions on the sale or
disposition of all of the Common Stock of
Pubco acquired by them in connection with
the Merger. In addition, for a period of one
year following the closing of the
Transactions, the Parent shall not register,
nor shall it take any action to facilitate
registration, under the Securities Act, the
shares of Pubco Common Stock issued pursuant
to the Merger.

The Provision entitled “13. Closing Costs” in the Term Sheet is hereby deleted
in its entirety and replaced with the following:

	 	 	 
	13. Closing Costs

	 	All fees and expenses relating to the
Transactions, including but not limited to
legal and accounting fees, will be payable
at Closing from the proceeds of the PPO. The
Parties understand that G&P shall be engaged
by Pubco to serve as its securities counsel
(“G&P Retainer”) prior to the Closing Date
and that fees and expenses of G&P incurred
by Pubco will similarly be payable at
Closing from the proceeds of the PPO. G&P
shall handle all securities matters
requested by Pubco (as defined below),
including, but not limited to, any
registration statements to be filed with the
SEC under the Securities Act of 1933 and any
compliance filing to be filed with the SEC
under the Securities Exchange Act of 1934
(e.g., 10-K, 10-Q, 8-K, 14C, S-8, S-4, etc.)
to the extent necessary to facilitate the
Closing. The terms and conditions of the G&P
Retainer will be subject to a written
agreement to be acceptable to Pubco and
Kreido prior to the retainer being
effective. G&P’s fee for such representation
shall be limited to a maximum of $150,000.
	 
	 	 
	 

	 	In addition, the fee of McGuire Woods LLP
for its representation of Kreido in
connection with the Transactions shall be
limited to a maximum of $175,000.

 

 

 

The Provision entitled “14. Exclusivity” in the Term Sheet is hereby deleted in
its entirety and replaced with the following:

	 	 	 
	14. Exclusivity

	 	From and after the Effective Date and
continuing through January 15, 2007 (the
“Exclusivity Period”), Kreido hereby
covenants and agrees that it will not enter
into any agreement or consummate any
transaction with any third party in whatever
form, other than in the ordinary course of
business (including, without limitation,
joint venture, sale, license, distribution
agreement, etc.) or enter into any other
transaction thatwould preclude the
consummation of the PPO and the Merger
Agreement consistent with the terms set
forth in this Term Sheet. During the
Exclusivity Period, Pubco will incur
additional legal and other costs and
expenses in connection with the negotiation
of the Transaction and certain due diligence
activities relating thereto. TCG shall have
the right, upon notice to the other parties
hereto, to terminate its obligations
hereunder at any time if the results of its
due diligence inquiry are unsatisfactory to
TCG, in TCG’s sole discretion.

SIGNATURE PAGE TO IMMEDIATELY FOLLOW

 

 

 

Other than the foregoing amendments, all other terms and conditions of the Term Sheet remain in
full force and effect.

AGREED TO AND ACCEPTED: This 25th day of

October, 2006

	 	 	 	 	 
	Tompkins Capital Group LLC

 	 	 
	By:  	/s/ Mark Tompkins
 	 	 
	 	Name:  	Mr. Mark Tompkins 	 	 
	 	Title:  	Manager 	 	 
	 
	Kreido Laboratories

 	 	 
	By:  	/s/ Joel A. Balbien
 	 	 
	 	Name:  	Dr. Joel A. Balbien 	 	 
	 	Title:  	Chief Executive Officerexv10w14

 

Exhibit 10.14

INDEMNITY AGREEMENT

This Indemnity Agreement, dated as of ___, 2007, is made by and between Kreido
Biofuels, Inc., a Nevada corporation (the “Company”), and _____________________(the
“Indemnitee”).

RECITALS

A. The Company is aware that competent and experienced persons are increasingly reluctant to
serve as directors, officers or agents of corporations unless they are protected by comprehensive
liability insurance or indemnification, due to increased exposure to litigation costs and risks
resulting from their service to such corporations, and due to the fact that the exposure frequently
bears no reasonable relationship to the compensation of such directors, officers and other agents.

B. The statutes and judicial decisions regarding the duties of directors and officers are
often difficult to apply, ambiguous, or conflicting, and therefore fail to provide such directors,
officers and agents with adequate, reliable knowledge of legal risks to which they are exposed or
information regarding the proper course of action to take.

C. Plaintiffs often seek damages in such large amounts and the costs of litigation may be so
enormous (whether or not the case is meritorious), that the defense and/or resolution of such
litigation is often beyond the personal resources of directors, officers and other agents.

D. The Company believes that it is unfair for its directors, officers and agents, and the
directors, officers and agents of its subsidiaries, to assume the risk of huge judgments and other
expenses which may occur in cases in which the director, officer or agent received no personal
profit and in cases where the director, officer or agent was not culpable.

E. The Company recognizes that the issues in controversy in litigation against a director,
officer or agent of a corporation, such as the Company or its subsidiaries, are often related to
the knowledge, motives and intent of such director, officer or agent, that he or she is usually the
only witness with knowledge of the essential facts and exculpating circumstances regarding such
matters, and that the long period of time which usually elapses before the trial or other
disposition of such litigation often extends beyond the time that the director, officer or agent
can reasonably recall such matters and may extend beyond the normal time for retirement for such
director, officer or agent with the result that he or she, after retirement or in the event of his
or her death, his or her spouse, heirs, executors or administrators, may be faced with limited
ability and undue hardship in maintaining an adequate defense, which may discourage such a
director, officer or agent from serving in that position.

F. Based upon their experience as business managers, the Board of Directors of the Company
(the “Board”) has concluded that, to retain and attract talented and experienced
individuals to serve as directors, officers and agents of the Company and its subsidiaries and to
encourage such individuals to take the business risks necessary for the success of the Company and
its subsidiaries, it is necessary for the Company to contractually indemnify its directors,
officers and agents and the directors, officers and agents of its subsidiaries, and to assume for
itself maximum liability for expenses and damages in connection with claims against such
directors, officers and agents in connection with their service to the Company and its
subsidiaries, and has further concluded that the failure to provide such contractual
indemnification could result in great harm to the Company and its subsidiaries and the Company’s
stockholders.

 

1

 

G. Section 78.7502, 78.751, and 78.752 of the Nevada Revised Statutes (the
“Indemnification Sections”) empowers the Company to indemnify its directors, officers,
employees and agents by agreement and to indemnify persons who serve, at the request of the
Company, as the directors, officers, employees or agents of other corporations, partnerships, joint
ventures or trusts, and expressly provides that the indemnification provided by the Indemnification
Sections is not exclusive.

H. The Company desires and has requested the Indemnitee to serve or continue to serve as a
director, officer or agent of the Company and/or one or more subsidiaries of the Company free from
undue concern for claims for damages arising out of or related to such services to the Company
and/or one or more subsidiaries of the Company.

I. Indemnitee is willing to serve, or to continue to serve, the Company and/or one or more
subsidiaries of the Company, provided that he or she is furnished the indemnity provided for
herein.

AGREEMENT

NOW, THEREFORE, the parties hereto, intending to be legally bound, hereby agree as follows:

1. Definitions.

(a) Agent. For the purposes of this Agreement, “agent” means any person who is or was
a director, officer, employee or other agent of the Company or of a subsidiary of the Company; or
is or was serving at the request of, for the convenience of, or to represent the interests of the
Company or a subsidiary of the Company as a director, officer, manager, employee or agent of
another foreign or domestic corporation, partnership, joint venture, limited liability company,
trust or other enterprise.

(b) Expenses and Liabilities. For purposes of this Agreement, “expenses” shall
include all out-of-pocket costs of any type or nature whatsoever (including, without limitation,
all attorneys’ fees and related disbursements), actually and reasonably incurred by the Indemnitee
in connection with either the investigation, defense, resolution or appeal of a proceeding or
establishing or enforcing a right to indemnification under this Agreement or the Indemnification
Sections or otherwise; and “liabilities” shall include any judgments, fines, ERISA excise taxes or
penalties, or amounts paid in settlement of a proceeding. “Expenses” and “liabilities” shall not
include any expenses or liabilities in connection with any claim made against the Indemnitee:

 

2

 

(i) if the claim is proved by final judgment in a court of law or other final adjudication to
have been based upon or attributable to the Indemnitee’s in fact having gained any personal profit
or advantage to which he or she was not legally entitled;

(ii) if it is proved by final judgment in a court of law or other final adjudication that such
indemnification is unlawful;

(iii) if it is proved by final judgment in a court of law or other final adjudication that the
Indemnitee is liable pursuant to Nevada Revised Statute 78.138;

(iv) for a disgorgement of profits made from the purchase and sale by the Indemnitee of
securities pursuant to Section 16(b) of the Securities Exchange Act of 1934, as amended (the
“Exchange Act”), or similar provisions of any state statutory law or common law;

(v) on account of any liability derived from a failure of the Indemnitee to timely file with
the U.S. Securities and Exchange Commission any reports and notices under Sections 13 or 16(a) of
the Exchange Act;

(vi) brought about or contributed to by the dishonesty of the Indemnitee seeking payment
hereunder; however, notwithstanding the foregoing, the Indemnitee shall be protected under this
Agreement as to any claims upon which suit may be brought against him or her by reason of any
alleged dishonesty on his or her part, unless a judgment or other final adjudication thereof
adverse to the Indemnitee shall establish that he or she committed (i) acts of active and
deliberate dishonesty, (ii) with actual dishonest purpose and intent, (iii) which acts were
material to the cause of action so adjudicated; or

(vii) for any judgment, fine or penalty which the Corporation is prohibited by applicable law
from paying as indemnity or for any other reason.

(c) Proceeding. For the purposes of this Agreement, “proceeding” means any
threatened, pending, or completed action, suit or other proceeding, whether civil, criminal,
administrative, or investigative.

(d) Subsidiary. For purposes of this Agreement, “subsidiary” means any corporation of
which more than 50% of the outstanding voting securities is owned directly or indirectly by the
Company, by the Company and one or more other subsidiaries, or by one or more other subsidiaries.

2. Agreement to Serve. The Indemnitee agrees to serve and/or continue to serve as
agent of the Company, at its will (or under separate agreement, if such agreement exists), in the
capacity Indemnitee currently serves as an agent of the Company, so long as he or she is duly
appointed or elected and qualified in accordance with the applicable provisions of the Bylaws of
the Company or any subsidiary of the Company or until such time as he or she tenders his or her
resignation in writing; provided, however, that nothing contained in this Agreement is intended to
create any right to continued employment by Indemnitee.

 

3

 

3. Liability Insurance.

(a) Maintenance of D&O Insurance. The Company hereby covenants and agrees that, so
long as the Indemnitee shall continue to serve as an agent of the Company and thereafter so long as
the Indemnitee shall be subject to any possible proceeding by reason of the fact that the
Indemnitee was an agent of the Company, the Company, subject to Section 3(c), shall promptly obtain
and maintain in full force and effect directors’ and officers’ liability insurance (“D&O
Insurance”) in reasonable amounts from established and reputable insurers.

(b) Rights and Benefits. In all policies of D&O Insurance, the Indemnitee shall be
named as an insured in such a manner as to provide the Indemnitee the same rights and benefits as
are accorded to the most favorably insured of the Company’s directors, if the Indemnitee is a
director; or of the Company’s officers, if the Indemnitee is not a director of the Company but is
an officer; or of the Company’s key employees, if the Indemnitee is not a director or officer but
is a key employee. Notwithstanding the preceding sentence, D&O Insurance may not provide
protection for an Indemnitee adjudged by a court of competent jurisdiction, after exhaustion of all
appeals therefrom, to be liable for intentional misconduct, fraud or a knowing violation of law,
except with respect to the advancement of expenses or indemnification ordered by a court.

(c) Limitation on Required Maintenance of D&O Insurance. Notwithstanding the
foregoing, the Company shall have no obligation to obtain or maintain D&O Insurance if the Company
determines in good faith that such insurance is not reasonably available, the premium costs for
such insurance are disproportionate to the amount of coverage provided, the coverage provided by
such insurance is limited by exclusions so as to provide an insufficient benefit, or the Indemnitee
is covered by similar insurance maintained by a subsidiary of the Company.

4. Mandatory Indemnification. Subject to Section 9 below, the Company shall indemnify
the Indemnitee as follows:

(a) Third Party Actions. If the Indemnitee is a person who was or is a party or is
threatened to be made a party to any proceeding (other than an action by or in the right of the
Company) by reason of the fact that he or she is or was an agent of the Company, or by reason of
anything done or not done by him or her in any such capacity, the Company shall indemnify the
Indemnitee against any and all expenses and liabilities of any type whatsoever (including, but not
limited to, judgments, fines, ERISA excise taxes and penalties, and amounts paid in settlement)
actually and reasonably incurred by him or her in connection with the investigation, defense,
resolution or appeal of such proceeding, provided the Indemnitee acted in good faith and in a
manner he or she reasonably believed to be in or not opposed to the best interests of the Company
and its stockholders, and, with respect to any criminal action or proceeding, had no reasonable
cause to believe his or her conduct was unlawful. The termination of any action, suit or
proceeding by judgment, order, settlement, conviction or upon a plea of nolo contendere or its
equivalent, shall not, of itself, create a presumption that the Indemnitee did not act in good
faith and in a manner which the Indemnitee reasonably believed to be in or not opposed to the best
interests of the Company, and with respect to any criminal action or proceeding, had reasonable
cause to believe that the Indemnitee’s conduct was unlawful.

 

4

 

(b) Derivative Actions. If the Indemnitee is a person who was or is a party or is
threatened to be made a party to any proceeding by or in the right of the Company by reason of the
fact that he or she is or was an agent of the Company, or by reason of anything done or not done by
him or her in any such capacity, the Company shall indemnify the Indemnitee against all expenses
actually and reasonably incurred by him or her in connection with the investigation, defense,
resolution or appeal of such proceeding, provided the Indemnitee acted in good faith and in a
manner he or she reasonably believed to be in or not opposed to the best interests of the Company
and its stockholders; except that no indemnification under this subsection 4(b) shall be made in
respect to any claim, issue or matter as to which such person shall have been finally adjudged to
be liable to the Company by a court of competent jurisdiction unless and only to the extent that
the court in which such proceeding was brought shall determine upon application that, despite the
adjudication of liability but in view of all the circumstances of the case, such person is fairly
and reasonably entitled to indemnity for such amounts which the court shall deem proper.

(c) Actions where Indemnitee is Deceased. If the Indemnitee is a person who was or is
a party or is threatened to be made a party to any proceeding by reason of the fact that he or she
is or was an agent of the Company, or by reason of anything done or not done by him or her in any
such capacity, and if prior to, during the pendency of after completion of such proceeding
Indemnitee becomes deceased, the Company shall indemnify the Indemnitee’s heirs, executors and
administrators against any and all expenses and liabilities of any type whatsoever (including, but
not limited to, judgments, fines, ERISA excise taxes and penalties, and amounts paid in settlement)
actually and reasonably incurred to the extent Indemnitee would have been entitled to
indemnification pursuant to Sections 4(a) or 4(b) above were Indemnitee still alive.

(d) Limitations. Notwithstanding the foregoing, the Company shall not be obligated to
indemnify the Indemnitee for expenses or liabilities of any type whatsoever for which payment is
actually made to or on behalf of Indemnitee under a valid and collectible insurance policy of D&O
Insurance, or under a valid and enforceable indemnity clause, by-law or agreement.

5. Partial Indemnification. If the Indemnitee is entitled under any provision of this
Agreement to indemnification by the Company for some or a portion of any expenses or liabilities of
any type whatsoever incurred by him or her in the investigation, defense, resolution or appeal of a
proceeding, but not entitled, however, to indemnification for all of the total amount hereof, the
Company shall nevertheless indemnify the Indemnitee for such total amount except as to the portion
hereof to which the Indemnitee is not entitled.

6. Mandatory Advancement of Expenses. Subject to Section 9(a) below, the Company
shall advance all expenses incurred by the Indemnitee in connection with the investigation,
defense, resolution or appeal of any proceeding to which the Indemnitee is a party or is threatened
to be made a party by reason of the fact that the Indemnitee is or was an agent of the Company.
Indemnitee hereby undertakes to repay such amounts advanced only if, and to the extent that, it
shall be determined ultimately that the Indemnitee is not entitled to be indemnified by the Company
as authorized hereby. The advances to be made hereunder shall be paid by the Company to the
Indemnitee within twenty (20) days following delivery of a written request therefor by the
Indemnitee to the Company. In the event that the Company fails to pay expenses
as incurred by the Indemnitee as required by this paragraph, Indemnitee may seek mandatory
injunctive relief from any court having jurisdiction to require the Company to pay expenses as set
forth in this paragraph. If Indemnitee seeks mandatory injunctive relief pursuant to this
paragraph, it shall not be a defense to enforcement of the Company’s obligations set forth in this
paragraph that Indemnitee has an adequate remedy at law for damages.

 

5

 

7. Notice and Other Indemnification Procedures.

(a) Notice by Indemnitee. Promptly after receipt by the Indemnitee of notice of the
commencement of or the threat of commencement of any proceeding, the Indemnitee shall, if the
Indemnitee believes that indemnification with respect thereto may be sought from the Company under
this Agreement, notify the Company of the commencement or threat of commencement thereof.

(b) Notice by Company. If, at the time of the receipt of a notice of the commencement
of a proceeding pursuant to Section 7(a) hereof, the Company has D&O Insurance in effect, the
Company shall give prompt notice of the commencement of such proceeding to the insurers in
accordance with the procedures set forth in the respective policies. The Company shall thereafter
take all necessary or desirable action to cause such insurers to pay, on behalf of the Indemnitee,
all amounts payable as a result of such proceeding in accordance with the terms of such policies.

(c) Defense. In the event the Company shall be obligated to pay the expenses of any
proceeding against the Indemnitee, the Company, if appropriate, shall be entitled to assume the
defense of such proceeding, with counsel reasonably acceptable to the Indemnitee, upon the delivery
to the Indemnitee of written notice of its election so to do. After delivery of such notice,
acceptance of such counsel by the Indemnitee and the retention of such counsel by the Company, the
Company will not be liable to the Indemnitee under this Agreement for any fees of counsel
subsequently incurred by the Indemnitee with respect to the same proceeding, provided that (i) the
Indemnitee shall have the right to employ his or her counsel in any such proceeding at the
Indemnitee’s expense; and (ii) if (A) the employment of counsel by the Indemnitee has been
previously authorized by the Company, (B) the Indemnitee shall have reasonably concluded that there
may be a conflict of interest between the Company and the Indemnitee in the conduct of any such
defense, or (C) the Company shall not, in fact, have employed counsel to assume the defense of such
proceeding, then the fees and expenses of Indemnitee’s counsel shall be at the expense of the
Company.

8. Determination of Right to Indemnification.

(a) Successful Defense. To the extent the Indemnitee has been successful on the
merits or otherwise in defense of any proceeding (including, without limitation, an action by or in
the right of the Company) to which the Indemnitee was a party by reason of the fact that he or she
is or was an agent of the Company at any time, the Company shall indemnify the Indemnitee against
all expenses of any type whatsoever actually and reasonably incurred by him or her in connection
with the investigation, defense or appeal of such proceeding.

 

6

 

(b) Other Situations. In the event that Section 8(a) is inapplicable, the Company
shall also indemnify the Indemnitee unless, and except to the extent that, the Company shall prove
by clear and convincing evidence in a forum listed in Section 8(c) below that the Indemnitee has
not met the applicable standard of conduct required to entitle the Indemnitee to such
indemnification.

(c) Selection of Forum. The Indemnitee shall be entitled to select the forum in which
the validity of the Company’s claim under Section 8(b) hereof that the Indemnitee is not entitled
to indemnification will be heard from among the following:

(i) A quorum of the Board consisting of directors who are not parties to the proceeding for
which indemnification is being sought;

(ii) The stockholders of the Company;

(iii) If a majority vote of a quorum of the Board, consisting of directors who are not parties
to the proceeding for which indemnification is being sought, so orders, by independent legal
counsel in a written opinion; or

(iv) If a quorum of the Board, consisting of directors who are not parties to the proceeding
for which indemnification is being sought, cannot be obtained, by independent legal counsel in a
written opinion.

(d) Submission to Forum. As soon as practicable, and in no event later than thirty
(30) days after written notice of the Indemnitee’s choice of forum pursuant to Section 8(c) above,
the Company shall, at its own expense, submit to the selected forum in such manner as the
Indemnitee or the Indemnitee’s counsel may reasonably request, its claim that the Indemnitee is not
entitled to indemnification; and the Company shall act in the utmost good faith to assure the
Indemnitee a complete opportunity to defend against such claim.

(e) Expenses Related to this Agreement. Notwithstanding any other provision in this
Agreement to the contrary, the Company shall indemnify the Indemnitee against all expenses incurred
by the Indemnitee in connection with any hearing or proceeding under this Section 8 involving the
Indemnitee and against all expenses incurred by the Indemnitee in connection with any other
proceeding between the Company and the Indemnitee involving the interpretation or enforcement of
the rights of the Indemnitee under this Agreement unless a court of competent jurisdiction finds
that each of the claims and/or defenses of the Indemnitee in any such proceeding was frivolous or
made in bad faith.

9. Exceptions. Any other provision herein to the contrary notwithstanding, the
Company shall not be obligated pursuant to the terms of this Agreement:

(a) Claims Initiated by Indemnitee. To indemnify or advance expenses to the
Indemnitee with respect to proceedings or claims initiated or brought voluntarily by the Indemnitee
and not by way of defense, unless (i) such indemnification is expressly required to be made by law,
(ii) the proceeding was authorized by the Board, (iii) such indemnification is provided by the
Company, in its sole discretion, pursuant to the powers vested in the Company under the Nevada
Revised Statutes or (iv) the proceeding is brought to establish or enforce a
right to indemnification under this Agreement or any other statute or law or otherwise as
required under the Indemnification Sections;

 

7

 

(b) Lack of Good Faith. To indemnify the Indemnitee for any expenses incurred by the
Indemnitee with respect to any proceeding instituted by the Indemnitee to enforce or interpret this
Agreement, if a court of competent jurisdiction determines that each of the material assertions
made by the Indemnitee in such proceeding was not made in good faith or was frivolous; or

(c) Unauthorized Settlements. To indemnify the Indemnitee under this Agreement for
any amounts paid in settlement of a proceeding unless the Company consents to such settlement,
which consent shall not be unreasonably withheld.

10. Non-exclusivity. The provisions for indemnification and advancement of expenses
set forth in this Agreement shall not be deemed exclusive of any other rights which the Indemnitee
may have under any provision of law, the Company’s Certificate of Incorporation or Bylaws, the vote
of the Company’s stockholders or disinterested directors, other agreements, or otherwise, both as
to action in his or her official capacity and to action in another capacity while occupying his or
her position as an agent of the Company, and the Indemnitee’s rights hereunder shall continue after
the Indemnitee has ceased acting as an agent of the Company and shall inure to the benefit of the
heirs, executors and administrators of the Indemnitee.

11. Enforcement. Any right to indemnification or advances granted by this Agreement
to Indemnitee shall be enforceable by or on behalf of Indemnitee in any court of competent
jurisdiction if (i) the claim for indemnification or advances is denied, in whole or in part, or
(ii) no disposition of such claim is made within ninety (90) days of request therefor. Indemnitee,
in such enforcement action, if successful in whole or in part, shall be entitled to be paid also
the expense of prosecuting his or her claim. It shall be a defense to any action for which a claim
for indemnification is made under this Agreement (other than an action brought to enforce a claim
for expenses pursuant to Section 6 hereof, provided that the required undertaking has been tendered
to the Company) that Indemnitee is not entitled to indemnification because of the limitations set
forth in Sections 4 and 9 hereof. Neither the failure of the Company (including its Board of
Directors or its stockholders) to have made a determination prior to the commencement of such
enforcement action that indemnification of Indemnitee is proper in the circumstances, nor an actual
determination by the Company (including its Board of Directors or its stockholders) that such
indemnification is improper, shall be a defense to the action or create a presumption that
Indemnitee is not entitled to indemnification under this Agreement or otherwise.

12. Subrogation. In the event the Company is obligated to make a payment under this
Agreement, the Company shall be subrogated to the extent of such payment to all of the rights of
recovery under an insurance policy or any other indemnity agreement covering the Indemnitee, who
shall execute all documents required and shall do all acts that may be necessary to secure such
rights and to enable the Company effectively to bring suit to enforce such rights.

 

8

 

13. Survival of Rights.

(a) All agreements and obligations of the Company contained herein shall continue during the
period Indemnitee is an agent of the Company and shall continue thereafter so long as Indemnitee
shall be subject to any possible claim or threatened, pending or completed action, suit or
proceeding, whether civil, criminal, arbitrational, administrative or investigative, by reason of
the fact that Indemnitee was serving in the capacity referred to herein.

(b) The Company shall require any successor to the Company (whether direct or indirect, by
purchase, merger, consolidation or otherwise) to all or substantially all of the business or assets
of the Company, expressly to assume and agree to perform this Agreement in the same manner and to
the same extent that the Company would be required to perform if no such succession had taken
place.

14. Interpretation of Agreement. It is understood that the parties hereto intend this
Agreement to be interpreted and enforced so as to provide indemnification to the Indemnitee to the
fullest extent permitted by law including those circumstances in which indemnification would
otherwise be discretionary.

15. Severability. If any provision or provisions of this Agreement shall be held to
be invalid, illegal or unenforceable for any reason whatsoever, (i) the validity, legality and
enforceability of the remaining provisions of the Agreement (including without limitation, all
portions of any paragraphs of this Agreement containing any such provision held to be invalid,
illegal or unenforceable, that are not themselves invalid, illegal or unenforceable) shall not in
any way be affected or impaired thereby, and (ii) to the fullest extent possible, the provisions of
this Agreement (including, without limitation, all portions of any paragraph of this Agreement
containing any such provision held to be invalid, illegal or unenforceable, that are not themselves
invalid, illegal or unenforceable) shall be construed so as to give effect to the intent manifested
by the provision held invalid, illegal or unenforceable and to give effect to Section 14 hereof.

16. Modification and Waiver. No supplement, modification or amendment of this
Agreement shall be binding unless executed in writing by both of the parties hereto. No waiver of
any of the provisions of this Agreement shall be deemed or shall constitute a waiver of any other
provisions hereof (whether or not similar) nor shall such waiver constitute a continuing waiver.

17. Notice. All notices, requests, demands and other communications under this
Agreement shall be in writing and shall be deemed duly given (i) if delivered by hand and receipted
for by the party addressee or (ii) if mailed by certified or registered mail with postage prepaid,
on the third business day after the mailing date. Addresses for notice to either party are as
shown on the signature page of this Agreement, or as subsequently modified by written notice.

18. Governing Law. This Agreement shall be governed exclusively by and construed
according to the laws of the State of Nevada as applied to contracts entered into and to be
performed entirely within Nevada.

[Signature Page Follows]

 

9

 

The parties hereto have entered into this Indemnity Agreement effective as of the date first
above written.

	 	 	 	 	 
	 	 	KREIDO BIOFUELS, INC., a Nevada corporation:
	 
	 	 	 	 
	 

	 	By:	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	 

	 	Title:	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	 

	 	Address:
	 	1140 Avenida Acaso
	 

	 	 	 	Camarillo, CA 93012
	 
	 	 	 	 
	 	 	INDEMNITEE:
	 
	 	 	 	 
	 
	 	 	 	 
	 	 	 
	 

	 	Signature	 	 
	 
	 	 	 	 
	 

	 	Name:	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	 

	 	Address:	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	 

	 	 	 	 

 

10

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00121-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00121-of-00352.parquet"}]]